T1	intervention 0 14	Weight lifting
T2	condition 59 69	lymphedema
T3	control 347 368	no exercise (control)
T4	location 528 540	Philadelphia
T5	No-of-participants 562 565	154
T6	eligibility 566 718	breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymph nodes removed and without clinical signs of BCRL at study entry
T7	duration 748 790	between October 1, 2005, and February 2007
T8	outcome-Measure 988 1001	Incident BCRL
T9	outcome-Measure 1098 1126	Clinician-defined BCRL onset
T10	No-of-participants 1226 1229	134
T12	intervention-value 1347 1350	11%
T13	intervention-value 1352 1353	8
T14	intervention-participants 1357 1359	72
T15	control-value 1406 1409	17%
T16	control-value 1411 1413	13
T17	control-participants 1417 1419	75
T18	outcome 1640 1659	incident BCRL onset
T19	intervention-value 1664 1666	7%
T20	intervention-value 1668 1669	3
T21	intervention-participants 1673 1675	45
T22	control-value 1722 1725	22%
T23	control-value 1727 1729	11
T24	control-participants 1733 1735	49
T25	outcome 1825 1853	Clinician-defined BCRL onset
T26	intervention-value 1866 1867	1
T27	control-value 1919 1920	3
T28	intervention-value 1949 1953	1.5%
T29	control-value 1957 1961	4.4%
T11	outcome 1323 1342	incident BCRL onset
